Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review

Journal of the American Geriatrics Society
Najla El MorabetFatma Karapinar-Çarkit

Abstract

To summarize the evidence on the prevalence and preventability of drug-related hospital readmissions. A systematic review was performed of studies that examined drug-related hospital readmissions. PubMed, EMBASE, and the Cochrane Library were searched from inception through August 2016. Reference lists and a citation analysis on Web of Science and Scopus were also consulted. Two reviewers extracted study data with dual assessment of risk of bias. Prevalence and preventability of readmission due to drugs were calculated. Data were qualitatively summarized according to outcome. Nineteen studies met the eligibility criteria. Nine measured readmissions due to drug-related problems, seven due to adverse drug reactions, two due to adverse drug events, and one due to drug-drug interactions. Rates of readmissions due to drugs varied from 3% to 64% (median 21%, interquartile range (IQR) 14-23%). Readmissions were deemed preventable in 5% to 87% of cases (median 69%, IQR 19-84%). Evidence regarding the risk factors for drug-related readmissions and drugs causing these readmissions was inconsistent. Although studies show high variability in prevalence and preventability of drug-related hospital readmissions, readmissions due to drugs seem...Continue Reading

References

Oct 1, 1991·Medical Care·L A BeroJ A Bird
Jun 1, 1991·The American Journal of Medicine·S E FranklL Goldman
May 2, 2000·Archives of Internal Medicine·J Benbassat, M Taragin
Nov 10, 2000·Lancet·I R Edwards, J K Aronson
Jun 14, 2002·Journal of Clinical Epidemiology·Patricia HalfonBernard Burnand
May 19, 2004·Journal of Internal Medicine·H DormannE G Hahn
May 19, 2004·Annals of Internal Medicine·Jonathan R NebekerMatthew H Samore
Jan 5, 2005·Annals of Internal Medicine·María-José Otero, Etienne Schmitt
Feb 5, 2008·Quality & Safety in Health Care·E M A WitheringtonA J Avery
Apr 4, 2008·European Journal of Clinical Pharmacology·Borja RuizCarmelo Aguirre
Apr 3, 2009·The New England Journal of Medicine·Stephen F JencksEric A Coleman
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
May 26, 2010·Age and Ageing·Marta Garcia-CaballosAurora Bueno-Cavanillas
Jun 29, 2010·Pharmacy World & Science : PWS·Glena R EllittTimothy F Chen
Oct 15, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Nazima AllaudeenAndrew Auerbach
Nov 3, 2010·British Journal of Clinical Pharmacology·Emma C DaviesMunir Pirmohamed
Feb 15, 2011·European Journal of Clinical Pharmacology·Lina M HellströmTommy Eriksson
Mar 30, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Carl van WalravenAlan J Forster
May 12, 2011·QJM : Monthly Journal of the Association of Physicians·L García-PérezA Sarría-Santamera
May 17, 2011·Journal of the American Geriatrics Society·Sarah S TeymoorianMark Woods
Jul 4, 2012·Annals of Internal Medicine·Sunil KripalaniUNKNOWN PILL-CVD (Pharmacist Intervention for Low Literacy in Cardiovascular Disease) Study Group
Jul 25, 2012·Population Health Management·Susan RobinsonDavid Vlahov
Oct 12, 2012·Journal of General Internal Medicine·Linda Calvillo-KingEthan A Halm
Dec 21, 2012·Journal of the American Geriatrics Society·Dominique Bonnet-ZamponiUNKNOWN Optimization of Medication in AGEd study group
Sep 17, 2013·Pharmacoepidemiology and Drug Safety·Luca PasinaPiermannuccio Mannucci
Nov 22, 2013·The Annals of Pharmacotherapy·Megan N WillsonDouglas L Weeks
Nov 29, 2013·British Journal of Clinical Pharmacology·Abdullah Al HamidZoe Aslanpour
Jul 22, 2014·International Journal of Surgery·Jan P VandenbrouckeUNKNOWN STROBE Initiative
Sep 30, 2014·JAMA Internal Medicine·Jessica Howard-AndersonNasim Afsar-Manesh
Oct 9, 2015·Hospital Pharmacy·Julin ThomasNathaniel Thompson-Moore
Oct 28, 2015·Journal of Cardiac Failure·Faraz S AhmadStephen E Kimmel
Feb 18, 2016·European Journal of Clinical Pharmacology·Laurent HauvillerHaleh Bagheri
Jul 28, 2016·Pediatrics·Sara L ToomeyMark A Schuster

❮ Previous
Next ❯

Citations

Aug 3, 2018·The Annals of Pharmacotherapy·Wubshet H TesfayeSyed Tabish R Zaidi
Jul 15, 2018·British Journal of Clinical Pharmacology·Stefanie ThevelinOlivia Dalleur
Jun 11, 2019·Acta Clinica Belgica·Julie HiasLorenz Van der Linden
May 28, 2019·International Journal of Clinical Pharmacy·Nanca Cebron LipovecMitja Kos
Nov 17, 2019·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Elien B UitvlugtFatma Karapinar-Çarkit
Mar 4, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Fatema A AlqenaeRichard N Keers
Jan 11, 2020·Drugs & Aging·Lorenz Van der LindenIsabel Spriet
Jun 1, 2020·Age and Ageing·Karen Cardwell
May 14, 2020·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Martin DawesDiana Dawes
Sep 11, 2020·International Journal of Clinical Pharmacy·Godelieve H M PonjeeFatma Karapinar-Çarkit
Feb 20, 2019·Medicines·Marios SpanakisEmmanouil G Spanakis
May 31, 2020·International Journal of Clinical Pharmacy·A E M J H LinkensK P G M Hurkens
Mar 29, 2020·BMC Health Services Research·Sophie A KitchenCorinne M Hohl
Oct 10, 2020·Journal of the American Pharmacists Association : JAPhA·Joseph R HergesKurt B Angstman
Jun 14, 2020·Research in Social & Administrative Pharmacy : RSAP·Sara DaliriFatma Karapinar-Çarkit
Nov 15, 2020·European Journal of Clinical Pharmacology·Mirjam KauppilaOuti Lapatto-Reiniluoto
Jan 25, 2021·International Journal of Medical Informatics·Katoo M MuyllePieter Cornu
Jan 21, 2021·The American Journal of Medicine·M Shawn McFarlandUNKNOWN writing on behalf of the Get the Medications Right Institute
Feb 11, 2021·Pharmacy : Journal of Pharmacy, Education and Practice·Helene StuderMarkus L Lampert
Feb 16, 2021·Annales pharmaceutiques françaises·F GervaisC Mouchoux
Apr 5, 2021·Journal of the American Pharmacists Association : JAPhA·Shelby KelshMichael Stout
Mar 17, 2020·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Harold J ManleyEduardo K Lacson
May 30, 2021·Research in Social & Administrative Pharmacy : RSAP·Elien B UitvlugtFatma Karapinar-Çarkit
Jun 7, 2021·International Journal of Medical Informatics·Leonie WesterbeekStephanie Medlock
Oct 15, 2020·International Journal of Clinical Pharmacy·Teddy NovaisChristelle Mouchoux
Jul 16, 2021·Therapeutic Advances in Psychopharmacology·H Abdullah-KoolmeesE R Heerdink
Jul 26, 2021·Research in Social & Administrative Pharmacy : RSAP·Holly FootChristopher Freeman
Aug 4, 2021·BMC Health Services Research·Bárbara PizettaGenival Araujo Dos Santos Júnior
Aug 10, 2021·Therapeutic Advances in Drug Safety·Chariclia ParadissisMichael Barras
Sep 7, 2021·International Journal of Clinical Practice·Tristan CoppesFatma Karapinar-Çarkit
Oct 7, 2021·European Journal of Clinical Pharmacology·O LaatikainenM Turpeinen
Aug 20, 2021·British Journal of Clinical Pharmacology·Sara DaliriFatma Karapinar-Çarkit

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.